199 related articles for article (PubMed ID: 33496558)
1. Human Metapneumovirus and Parainfluenza Virus Infections in Lung Transplant Recipients: The Effects on Lung Allograft and Clinical Outcomes.
Permpalung N; Sait AS; Bazemore K; Avery RK; Mathew J; Shah PD
Transplantation; 2021 Dec; 105(12):2625-2631. PubMed ID: 33496558
[TBL] [Abstract][Full Text] [Related]
2. Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies.
de Zwart A; Riezebos-Brilman A; Lunter G; Vonk J; Glanville AR; Gottlieb J; Permpalung N; Kerstjens H; Alffenaar JW; Verschuuren E
Clin Infect Dis; 2022 Jul; 74(12):2252-2260. PubMed ID: 35022697
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients.
de Zwart AES; Riezebos-Brilman A; Alffenaar JC; van den Heuvel ER; Gan CT; van der Bij W; Kerstjens HAM; Verschuuren EAM
Am J Transplant; 2020 Dec; 20(12):3529-3537. PubMed ID: 32449200
[TBL] [Abstract][Full Text] [Related]
5. Human metapneumovirus in lung transplant recipients: characteristics and outcomes.
Niggli F; Huber LC; Benden C; Schuurmans MM
Infect Dis (Lond); 2016; 48(11-12):852-6. PubMed ID: 27385394
[TBL] [Abstract][Full Text] [Related]
6. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 social distancing measures on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilisation of lung function.
de Zwart AES; Riezebos-Brilman A; Lunter GA; Neerken ECU; van Leer-Buter CC; Alffenaar JC; van Gemert AP; Erasmus ME; Gan CT; Kerstjens HAM; Vonk JM; Verschuuren EAM
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35896214
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
9. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients.
Weinberg A; Lyu DM; Li S; Marquesen J; Zamora MR
Transpl Infect Dis; 2010 Aug; 12(4):330-5. PubMed ID: 20456714
[TBL] [Abstract][Full Text] [Related]
10. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology.
Larcher C; Geltner C; Fischer H; Nachbaur D; Müller LC; Huemer HP
J Heart Lung Transplant; 2005 Nov; 24(11):1891-901. PubMed ID: 16297797
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study.
Permpalung N; Bazemore K; Chiang TP; Mathew J; Barker L; Nematollahi S; Cochran W; Sait AS; Avery RK; Shah PD
Transplantation; 2021 Sep; 105(9):2072-2079. PubMed ID: 34075005
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
[TBL] [Abstract][Full Text] [Related]
13. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
14. Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction.
Pennington KM; Aversa M; Martinu T; Johnson B; Husain S
Transpl Infect Dis; 2022 Dec; 24(6):e13986. PubMed ID: 36380578
[TBL] [Abstract][Full Text] [Related]
15. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
[TBL] [Abstract][Full Text] [Related]
16. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.
Gerna G; Vitulo P; Rovida F; Lilleri D; Pellegrini C; Oggionni T; Campanini G; Baldanti F; Revello MG
J Med Virol; 2006 Mar; 78(3):408-16. PubMed ID: 16419110
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis.
Dare R; Sanghavi S; Bullotta A; Keightley MC; George KS; Wadowsky RM; Paterson DL; McCurry KR; Reinhart TA; Husain S; Rinaldo CR
J Clin Microbiol; 2007 Feb; 45(2):548-52. PubMed ID: 17065270
[TBL] [Abstract][Full Text] [Related]
18. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.
Hopkins P; McNeil K; Kermeen F; Musk M; McQueen E; Mackay I; Sloots T; Nissen M
Am J Respir Crit Care Med; 2008 Oct; 178(8):876-81. PubMed ID: 18658110
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.
Peghin M; Los-Arcos I; Hirsch HH; Codina G; Monforte V; Bravo C; Berastegui C; Jauregui A; Romero L; Cabral E; Ferrer R; Sacanell J; Román A; Len O; Gavaldà J
Clin Infect Dis; 2019 Sep; 69(7):1192-1197. PubMed ID: 30561555
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
